Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
High Physical Activity Reduces Cancer
Health
April 7, 2026 Evan Vega

UK Biobank Study: Highest Physical Activity Levels Cut Cancer Risk by 26% Across 13 Types

A UK Biobank study found that highest physical activity levels reduce risk of 13 cancer types by 26%, based on accelerometer data.

Read More
FDA Approves Oral Wegovy
Health
April 7, 2026 Evan Vega

Novo Nordisk’s Oral Wegovy Gains FDA Approval, 25mg Semaglutide Tablet Launches for Weight Management

The FDA approved Novo Nordisk’s 25 mg oral Wegovy semaglutide tablet for adult weight management, launching in January 2026.

Read More
DNA Smart Cancer Targeting
Health
April 6, 2026 Evan Vega

DNA-Based ‘Smart’ Drug Targets Cancer Cells with Precision, Activates Only on Tumor Markers

Researchers developed a DNA-based drug that activates only in cancer cells expressing two tumor markers, improving targeted treatment precision.

Read More
Fasting-mimicking diet benefits Crohn's
Health
April 4, 2026 Evan Vega

Fasting-Mimicking Diet Provides Real Relief in New Crohn’s Disease Clinical Trial

A Stanford trial found a five-day monthly fasting-mimicking diet improved symptoms and remission in 69% of Crohn’s disease patients.

Read More
Aging lung cells overreact
Health
April 4, 2026 Evan Vega

Aging Lung Cells Trigger Dangerous Immune Overresponse to Flu and COVID in Older Adults, Study Finds

A UCSF study finds aging lung cells trigger harmful immune overreactions to flu and COVID-19 in older adults, worsening lung damage.

Read More
PDUFA Dates Istuximab CAR-T
Health
April 4, 2026 Evan Vega

ASH Highlights PDUFA Dates for Subcutaneous Istuximab in Myeloma, CAR T-Cell Therapy for AML/ALL/MDS

The FDA set an April 23, 2026 PDUFA date for subcutaneous isatuximab in relapsed/refractory multiple myeloma, following positive phase 3 trial results.

Read More
Pope Leo XIV, the first American-born pope, photographed in May 2025
Health
April 4, 2026 Evan Vega

Pope Leo XIV’s Good Friday Cross Procession Spotlights Physical Devotion and Spiritual Wellness

Pope Leo XIV’s decision to carry the full wooden cross through all 14 Stations at Rome’s Colosseum drew renewed attention to the connection between physical acts of religious devotion and spiritual wellness.

Read More
Type 2 Diabetes GLP-1s
Health
April 3, 2026 Evan Vega

VA Study: Type 2 Diabetes Patients Quitting GLP-1s Face Reversed Weight Loss and Higher Heart Risks

A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.

Read More
Denali Avlayah MPS II
Health
April 3, 2026 Evan Vega

Denali’s Avlayah Reduces CSF Heparan Sulfate by 91% in Phase 1/2 Trial for MPS II

Denali’s Avlayah reduced cerebrospinal fluid heparan sulfate by 91% in a Phase 1/2 trial for pediatric Hunter syndrome patients.

Read More
Early 2026 health updates
Health
April 2, 2026 Evan Vega

January-February 2026 (vaccine recommendations, oral GLP-1 approvals, appropriations bill)

The CDC updated childhood vaccine guidelines, reducing routine immunizations from 17 to 11 diseases and shifting six vaccines to high-risk groups.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.